212 related articles for article (PubMed ID: 6260435)
1. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Trager GM; White GW; Zimelis VM; Bryk DA; Panwalker AP
Chemotherapy; 1981; 27(1):34-8. PubMed ID: 6260435
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Braveny I; Machka K; Elsser R
Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
[TBL] [Abstract][Full Text] [Related]
3. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
5. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
7. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
Perrymann F; Flournoy DJ; Qadri SM
Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Pulverer G; Peters G
Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
[No Abstract] [Full Text] [Related]
14. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
15. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Mintz L; Drew WL
Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
Daschner FD; Goerke C; Bassler M; Just M
Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
